Open Access

ARTICLE

Impact of durable ventricular assist devices on post‐transplant outcomes in adults with congenital heart disease

Ari Cedars¹, Luke Burchill², S. Lucy Roche³, Jonathan Menachem⁴, Kelly Axsom⁵, Kristen Tecson⁶

1 University of Texas Southwestern Medical School, Dallas, Texas, USA
2 University of Melbourne, Melbourne, Australia
3 University of Toronto, Toronto, Ontario, Canada
4 Vanderbilt University, Nashville, Tennessee, USA
5 Columbia University, New York, New York, USA
6 Baylor University Medical Center, Dallas, Texas, USA

* Corresponding Author: Ari Cedars, The University of Texas Southwestern Medical Center, 2001 Inwood Rd. Suite WC05.852, Dallas, TX 75390, USA. Email:

Congenital Heart Disease 2019, 14(6), 958-962. https://doi.org/10.1111/chd.12851

Abstract

Background: There are no published data on post‐transplant outcomes in durable ven‐ tricular assist device (VAD)‐supported adult congenital heart disease (ACHD) patients.
Methods: We compared post‐transplant outcomes in VAD‐supported vs non‐VAD‐ supported ACHD patients using the Scientific Registry of Transplant Recipients.
Results: At 1 year, there was no difference in post‐transplant mortality between VAD‐supported (12 patients) and non‐VAD‐supported (671 patients) ACHD patients.
Conclusions: In appropriate ACHD patients, VAD use as a bridge to transplant is a reasonable strategy.

---

Keywords

---